- Sanuwave Health (SNWV, Financial) to join the Russell 2000®, 3000®, and Microcap® Indexes effective June 30, 2025.
- Russell indexes are crucial for investment managers, with $10.6 trillion in assets benchmarked.
- Inclusion expected to enhance visibility and liquidity for Sanuwave Health.
Sanuwave Health, Inc. (SNWV), a leading provider of non-invasive wound care solutions, has been selected for inclusion in the prestigious Russell 2000® Index. The company will also be included in the broader Russell 3000® Index and Russell Microcap® Index as part of the 2025 Russell indexes reconstitution. This development will be effective after the U.S. market opens on June 30, 2025.
The Russell indexes are essential for investment managers and institutional investors, as they capture the 4,000 largest U.S. stocks by market capitalization. Sanuwave's inclusion in these indexes is significant, considering approximately $10.6 trillion in assets were benchmarked to these indexes as of June 2024.
The inclusion in multiple Russell indexes is expected to provide Sanuwave Health with increased visibility to institutional investors. This could potentially enhance the company's trading liquidity and attract passive fund inflows, thereby supporting broader market engagement with Sanuwave's regenerative medicine technologies.
Sanuwave Health specializes in the innovation and commercialization of its patented, non-invasive medical systems, focusing on wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions. The company's energy transfer technologies underline its commitment to advancing the field of regenerative medicine.
